NewsMedia highlights of Eyquem Lab's research.Peptide–RNP delivery paper highlighted by Nature Reviews Bioengineering Read More >> Peptide–RNP delivery paper highlighted by Nature Biomedical Engineering Read More >> HIT-T cell paper highlighted in Cancer Cell Read More >> Response to Low Antigen Density Is Improved by HLA-Independent T-cell Receptors Read More >> CRISPR-driven CARs Read More >> CRISPR genome editing and immunotherapy – the early adopter Read More >> CRISPR gene therapy is enhancing T-cell immunotherapy treatment of cancer and treatments in people could be available within 2 to 3 years Read More >> Researchers Use CRISPR Gene-Editing Tool to Help Turn Immune Cells against Tumors Read More >> Using CRISPR to Supercharge Cancer-Killing Immune Cells Read More >> AACR 2018: An off-the-shelf, dual-targeted CAR T-cell product showed promising results in preclinical studies Read More >> Curing Cancer with CRISPR Read More >> Pancreatic cancer cells digest extracellular protein Read More >>
